American tennis star Coco Gauff has commented on the Women’s Tennis Association’s (WTA) policy concerning SRY gene testing to ensure fair competition. While Gauff appears to support the policy aimed at excluding males from the women’s game, she also expresses her support for the transgender community.

Gauff stated, “I understand the reasoning behind it. I do think that this kind of conversation has created a lot of animosity toward the trans community, which I’m not really a big fan of, but I also understand the biological difference and the need to protect that and preserve that. So, I think it’s a conversation that is very nuanced and I need to have a nuanced answer.”

She acknowledged the importance of fairness in women’s sports but criticized how the debate can lead to unfounded attacks on the trans community.
Gauff added, “I guess I kind of agree with trying to protect the fairness in women’s sports. But I also do not like the attack that it is creating for people who don’t really care, but just want to use this as a reason to attack the trans community. So, I’m not really a big fan of that either.”

Gauff also faced challenges in expressing her viewpoint clearly without misinterpretation, yet she emphasized her dual support for the transgender community and the need for fairness in sports.

Her comments were made after her victory against Kayla Day in the first round of the National Open in Toronto. These remarks echo the sentiments of another top player, Aryna Sabalenka. Sabalenka stated, “I think it’s really important to keep the fairness in our tour. Biologically, men are way stronger than women, so I feel like it would not really be fair for women to compete against biological men.”

The WTA’s revised eligibility policy requires SRY gene screening, possible through a cheek swab, blood test, or saliva sample. A negative result allows immediate competition on the WTA Tour, while a positive result necessitates further medical assessment before clearance. Players must acknowledge that declining to undergo testing could result in disciplinary actions.

The WTA asserts that the policy aims to ensure equal athletic opportunities and maintain fair competition for all participants in its tournaments. It was approved after consulting members and reviewing evolving eligibility standards in international women’s sports.